• FirefoxInstall the new Firefox »
  •  Dow Down1.11% Nasdaq Down0.94%

    Enanta Pharmaceuticals, Inc. (ENTA)

    -NasdaqGS
    30.62 Down 0.74(2.36%) Mar 31, 4:00PM EDT
    Add to Portfolio
    Analyst EstimatesGet Analyst Estimates for:
    Earnings EstCurrent Qtr.
    Mar 15
    Next Qtr.
    Jun 15
    Current Year
    Sep 15
    Next Year
    Sep 16
    Avg. Estimate1.630.354.753.79
    No. of Analysts4.004.004.006.00
    Low Estimate1.490.204.391.34
    High Estimate1.820.515.405.60
    Year Ago EPS-0.282.611.804.75
    Revenue EstCurrent Qtr.
    Mar 15
    Next Qtr.
    Jun 15
    Current Year
    Sep 15
    Next Year
    Sep 16
    Avg. Estimate60.84M19.25M191.90M154.54M
    No. of Analysts5556
    Low Estimate58.00M15.75M175.10M82.78M
    High Estimate66.00M24.20M206.32M201.00M
    Year Ago Sales2.16M42.05M47.74M191.90M
    Sales Growth (year/est)2,716.70%-54.20%302.00%-19.50%
    Earnings HistoryMar 14Jun 14Sep 14Dec 14
    EPS Est0.081.67-0.333.82
    EPS Actual-0.282.61-0.272.18
    Difference-0.360.940.06-1.64
    Surprise %-450.00%56.30%18.20%-42.90%
    EPS TrendsCurrent Qtr.
    Mar 15
    Next Qtr.
    Jun 15
    Current Year
    Sep 15
    Next Year
    Sep 16
    Current Estimate1.630.354.753.79
    7 Days Ago1.630.354.753.79
    30 Days Ago1.780.294.743.64
    60 Days Ago2.371.999.874.11
    90 Days Ago2.142.189.853.68
    EPS RevisionsCurrent Qtr.
    Mar 15
    Next Qtr.
    Jun 15
    Current Year
    Sep 15
    Next Year
    Sep 16
    Up Last 7 Days0000
    Up Last 30 Days0001
    Down Last 30 Days0000
    Down Last 90 DaysN/AN/AN/AN/A
    Growth EstENTAIndustrySectorS&P 500
    Current Qtr.682.10%N/A-82.20%8.10%
    Next Qtr.-86.60%N/A-90.70%14.20%
    This Year163.90%N/A21.50%2.60%
    Next Year-20.20%N/A25.50%13.10%
    Past 5 Years (per annum)0.00%N/AN/AN/A
    Next 5 Years (per annum)N/A14.32%15.11%7.57%
    Price/Earnings (avg. for comparison categories)6.69-20.727.1218.57
    PEG Ratio (avg. for comparison categories)N/A33.668.171.52
    Currency in USD.